← Browse by Condition
Medical Condition

alcohol dependence

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for alcohol dependence sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — alcohol dependence Clinical Trials

How many clinical trials are currently recruiting for alcohol dependence?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for alcohol dependence, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for alcohol dependence?
alcohol dependence research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a alcohol dependence clinical trial?
Eligibility criteria for alcohol dependence trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Top Sponsors
Charite University, Berlin, Germany 1 trial
Inventage Lab., Inc. 1 trial
University of Iowa 1 trial
Brainsway 1 trial

Recruiting Clinical Trials

NCT06308484
Recruiting
Neuromodulation and Mindfulness Patients With AUD
Enrollment
140 pts
Location
Germany
Sponsor
Charite University, Berlin, Ge...
View Trial →
NCT05620940 Phase 1
Recruiting
A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.
Enrollment
40 pts
Location
Australia
Sponsor
Inventage Lab., Inc.
View Trial →
NCT06405607 Phase 2
Recruiting
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
Enrollment
80 pts
Location
United States
Sponsor
University of Iowa
View Trial →
NCT07216872
Recruiting
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)
Enrollment
186 pts
Location
United States, Israe...
Sponsor
Brainsway
View Trial →

Related Conditions

alcohol use disorder (2) alcohol abuse (2) opioid dependence (1) multiple sclerosis (1) alcoholism (1) alcohol abuse dependence (1) alcohol addiction (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology